Prognose
Vi har ingen analytikerdata for denne virksomhed.
Diskussioner i communityet
Der er endnu ingen diskussion om dette aktiv.
Start diskussionNyheder Til nyhedsfeedet
Xlife Sciences: an investment made three years ago would have lost 75.25%
An investment in Xlife Sciences worth 10,000 CHF three years ago (price 40.00 CHF) would have shrunk to 2,475.00 CHF as of 08.10.2026 (closing price 9.90 CHF), a loss of 75.25%. The most recent market value of Xlife Sciences is 56.46 million CHF. Stock splits and dividends are not included in the calculation. » Mere på finanzen.net
Xlife Sciences reports widened half-year loss and focuses on Veraxa development
In the first half of 2026 Xlife Sciences recorded sales of just under 0.5 million Swiss francs and a loss per share of 29.10 francs (previous year: 0.53 francs). Cash and cash equivalents stood at around 0.6 million at the end of June, total assets fell to 346.8 million and equity to 206.3 million Swiss francs. After the Nasdaq listing of portfolio company Veraxa Biotech, Xlife is concentrating on the operational development of its oncology pipeline, industrial partnerships and the commercialization of selected projects. » Mere på finanzen.net
Xlife Sciences stock down 24.77% since a year ago
If investors had bought Xlife Sciences a year ago with 10,000 CHF (closing price then 21.40 CHF), the investment would be worth 7,523.36 CHF today. The price decline corresponds to a loss of 24.77 percent; the market capitalization was most recently 92.80 million CHF. » Mere på finanzen.net
Xlife Sciences: investment from three years ago would have incurred around 56.4% loss
Someone who bought CHF 10,000 of Xlife Sciences shares on 17.07.2023 (closing price CHF 40.40) would have held 247.525 shares. At the closing price on 16.07.2026 of CHF 17.60, the holding would be worth CHF 4,356.44, a decline of 56.44%. All Xlife Sciences shares were most recently quoted with a market value of CHF 102.52 million; stock splits and dividends are not taken into account in the calculation. » Mere på finanzen.net
Xlife Sciences: one-year loss of 8.4% on investment in the stock
An investment of CHF 1,000 in Xlife Sciences one year ago (purchase price CHF 19.65) would have been worth only CHF 916.03 at the closing price on 09.07.2026 (CHF 18.00), a decline of 8.40%. The most recently reported market capitalization of Xlife Sciences is CHF 107.28 million. Stock splits and dividends were not taken into account in the calculation. » Mere på finanzen.net